A Phase Ⅰ b Clinical Study of ART101 Injection

Clinical trial NCT07614308 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07614308
Sponsor: Arnatar Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension (HTN)

Start date: 2025-10-27
Primary completion: 2026-10-14
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.